Genomic Copy Number Variation and TERT promoter mutation analyses as tools to predict the response to targeted therapy in BRAFmutated metastatic melanoma patients

Genomic Copy Number Variation and TERT promoter mutation analyses as tools to predict the response to targeted therapy in BRAFmutated metastatic melanoma patients

Tipologia

Ricerca di base/clinica

Stato

aperto

Copertura

Nazionale

Ruolo dell'Istituto

Capofila

Ente finanziatore

IOV - IRCCS

Anno di finanziamento

2018

Principal Investigator

Dott.ssa Chiara Menin
Scroll to Top